Clinical Trials Directory

Trials / Completed

CompletedNCT03311165

Epidemiological Study of Neonatal Acute Respiratory Distress Syndrome (ARDS)

Risk Factors, Clinical Course, Treatment and Prognosis of Neonatal Acute Respiratory Distress Syndrome (ARDS): A Prospective, Observational Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,000 (actual)
Sponsor
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
Sex
All
Age
1 Minute – 1 Month
Healthy volunteers

Summary

Neonatal acute respiratory distress syndrome(ARDS) is a rare but often severe respiratory disorder. The incidence remains unclear and mortality is about 30%-60%. It is characterized by acute, refractory hypoxemia, persistent respiratory distress and decreased lung compliance. Evaluation and comparison of various clinical studies conducted were hindered by a lack of uniformity in diagnostic criteria.

Detailed description

In 2017, the neonatal acute respiratory distress syndrome(ARDS) Consortium Working Group has proposed diagnostic criteria for neonatal ARDS. The study consists of a prospective, multicentre, web-based,cohort study in China in which neonates who fulfil the new criteria definition are enrolled in order to: describe the epidemiology, clinical course, and prognosis of neonates affected by neonatal ARDS; identify a list of risk factors for neonatal ARDS, as it exists for adults and older children with ARDS; and guide future studies.

Conditions

Interventions

TypeNameDescription
OTHERno interventionno intervention was given

Timeline

Start date
2018-01-01
Primary completion
2019-06-30
Completion
2019-06-30
First posted
2017-10-17
Last updated
2020-01-09

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03311165. Inclusion in this directory is not an endorsement.